Genetic Technologies Ltd Cash Flow-to-Debt Ratio
Genetic Technologies Ltd cash flow-to-debt ratio. Genetic Technologies Ltd (GENE) has a Cash Flow-to-Debt Ratio of -1.30x as of June 2024, meaning its operating cash flow of $-5.67 Million could theoretically repay -1% of its total liabilities ($4.36 Million) in one year. Check GENE operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Genetic Technologies Ltd (2000–2024)
Cash flow-to-debt ratio of Genetic Technologies Ltd from 2000 to 2024. Historical debt coverage capacity for Genetic Technologies Ltd across 25 annual periods. Check Genetic Technologies Ltd (GENE) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Genetic Technologies Ltd Cash Flow-to-Debt Ratio by Year (2000–2024)
Genetic Technologies Ltd cash flow-to-debt ratio by year from 2000 to 2024. Year-by-year debt coverage analysis for Genetic Technologies Ltd. For the full cash flow conversion analysis, see GENE cash flow metrics.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -2.22x | $-9.68 Million | $4.36 Million | ▲ +15.6% |
| 2023 | -2.63x | $-9.72 Million | $3.69 Million | ▼ -103.3% |
| 2022 | -1.29x | $-5.66 Million | $4.37 Million | ▲ +70.4% |
| 2021 | -4.38x | $-6.30 Million | $1.44 Million | ▼ -25.7% |
| 2020 | -3.48x | $-5.71 Million | $1.64 Million | ▲ +14.3% |
| 2019 | -4.07x | $-6.07 Million | $1.49 Million | ▼ -4.9% |
| 2018 | -3.88x | $-5.64 Million | $1.45 Million | ▲ +13.0% |
| 2017 | -4.46x | $-6.81 Million | $1.53 Million | ▲ +18.9% |
| 2016 | -5.49x | $-7.73 Million | $1.41 Million | ▲ +0.2% |
| 2015 | -5.51x | $-9.69 Million | $1.76 Million | ▼ -145.6% |
| 2014 | -2.24x | $-10.99 Million | $4.90 Million | ▲ +23.6% |
| 2013 | -2.93x | $-7.52 Million | $2.56 Million | ▲ +22.0% |
| 2012 | -3.76x | $-7.67 Million | $2.04 Million | ▼ -455.3% |
| 2011 | 1.06x | $2.23 Million | $2.11 Million | ▲ +163.1% |
| 2010 | -1.68x | $-4.30 Million | $2.56 Million | ▼ -31.9% |
| 2009 | -1.27x | $-6.10 Million | $4.79 Million | ▼ -1097.0% |
| 2008 | 0.13x | $423.68K | $3.32 Million | ▼ -76.5% |
| 2007 | 0.54x | $2.20 Million | $4.05 Million | ▲ +137.0% |
| 2006 | -1.47x | $-6.13 Million | $4.18 Million | ▼ -45.1% |
| 2005 | -1.01x | $-6.58 Million | $6.51 Million | ▼ -18.9% |
| 2004 | -0.85x | $-4.52 Million | $5.32 Million | ▼ -153.9% |
| 2003 | -0.33x | $-993.71K | $2.97 Million | ▲ +81.2% |
| 2002 | -1.78x | $-3.32 Million | $1.86 Million | ▼ -29.1% |
| 2001 | -1.38x | $-2.23 Million | $1.62 Million | ▼ -448.9% |
| 2000 | -0.25x | $-318.68K | $1.27 Million | — |